ArticleFrontiers in immunology2024

Pan-cancer analysis shows that BCAP31 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types.

Yangyong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.